Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Reply to Dünser et al.

  • 33 Accesses

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752-1758

  2. 2.

    Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D’Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125

  3. 3.

    Bucher M, Hobbhahn J, Taeger K, Kurtz A (2002) Cytokine-mediated downregulation of vasopressin V (1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 282:R979–R984

  4. 4.

    Spitzer JA, Turco ER, Deaciuc IV, Roth BL (1987) Perturbation of transmembrane signaling mechanisms in acute and chronic endotoxemia. Prog Clin Biol Res 236A:401–418

  5. 5.

    Mutlu GM, Factor P (2004) Role of vasopressin in the management of septic shock. Intensive Care Med 30:1276-1291

Download references

Author information

Correspondence to Gökhan M. Mutlu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mutlu, G.M., Factor, P. Reply to Dünser et al.. Intensive Care Med 30, 1983 (2004). https://doi.org/10.1007/s00134-004-2395-1

Download citation

Keywords

  • Septic Shock
  • Vasopressin
  • Care Community
  • Receptor Sensitivity
  • Late Phenomenon